Sales decline 28.11% to Rs 108.07 crore
Net Loss of Parabolic Drugs reported to Rs 24.46 crore in the quarter ended December 2013 as against net loss of Rs 25.59 crore during the previous quarter ended December 2012. Sales declined 28.11% to Rs 108.07 crore in the quarter ended December 2013 as against Rs 150.32 crore during the previous quarter ended December 2012. ParticularsQuarter EndedDec. 2013Dec. 2012% Var.Sales108.07150.32 -28 OPM %1.444.38 -PBDT-18.37-11.57 -59 PBT-35.40-24.59 -44 NP-24.46-25.59 4Powered by Capital Market - Live News